Panagora Asset Management Inc Assembly Biosciences, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$3.14 - $3.9 $3,435 - $4,266	-1,094 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$3.8 - $4.56 $710,068 - $852,081	-186,860 Reduced 99.42%	1,094 $4,000
Q1 2021 May 12, 2021	BUY	$4.33 - $6.63 $187,822 - $287,589	43,377 Added 30.0%	187,954 $865,000
Q4 2020 Feb 10, 2021	BUY	$4.87 - $17.29 $7,066 - $25,087	1,451 Added 1.01%	144,577 $875,000
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $1.28 Million - $2.3 Million	85,022 Added 146.33%	143,126 $2.35 Million
Q2 2020 Aug 12, 2020	BUY	$14.57 - $23.96 $846,575 - $1.39 Million	58,104 New	58,104 $1.36 Million
Q3 2019 Nov 12, 2019	SELL	$9.83 - $14.82 $97,661 - $147,236	-9,935 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$12.9 - $20.8 $128,161 - $206,648	9,935 New	9,935 $134,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.